NSN 6505-01-350-0355
Part Details | FELODIPINE EXTENDED-RELEASE TABLETS
6505-01-350-0355
Alternate Parts: NDC57237011001, NDC57237-0110-01, NDC68462023501, NDC68462-0235-01, NDC00603358321, NDC00603-3583-21, NDC23155005001, NDC23155-0050-01, NDC00378501301, NDC00378-5013-01, 6505-01-350-0355, 01-350-0355, 6505013500355, 013500355
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | DEC 08, 1991 | 01-350-0355 | 48109 ( FELODIPINE EXTENDED-RELEASE TABLETS ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-350-0355
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC57237-0110-01 | 71NU9 | CITRON PHARMA LLC |
| NDC68462-0235-01 | 7A4E3 | GLENMARK PHARMACEUTICALS INC., USA |
| NDC00603-3583-21 | 0VZ12 | GLOCOM, INC. |
| NDC23155-0050-01 | 5TB00 | HERITAGE PHARMACEUTICALS INCDBA HERITAGE PHARMAOEUTICALS AVE |
| NDC00378-5013-01 | 3KJG9 | MYLAN PHARMACEUTICALS INC. |
Technical Data | NSN 6505-01-350-0355
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB10.000 MILLIGRAMS FELODIPINE |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| FEATURES PROVIDED | CHILD RESISTANT CLOSURE |
| SPECIAL FEATURES | STORE AT 20 TO 25 C (68 TO 77 F); EXCURIONS PERMITTED TO 15 TO 30 C (59 TO 86 F).?SEE USP CONTROLLED ROOM TEMPERATURE| |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | FELODIPINE EXTENDED RELEASE TABLETS 10MG 100S BT |
